Ovidrel After Acute Illness: When to Restart Your Trigger Shot Safely

What Ovidrel Does and Why Timing Is Everything

Ovidrel delivers a precise 250 mcg dose of recombinant human chorionic gonadotropin (r-hCG) subcutaneously to trigger the final maturation of oocytes and ovulation. In assisted reproductive technology (ART), the trigger shot is scheduled with near-minute precision because egg retrieval is performed 34 to 36 hours after injection, a window calibrated to catch mature oocytes before natural ovulation occurs.

Miss the window by even a few hours, and the retrieval catches immature or already-released eggs. That precision is what makes acute illness so new.

How r-hCG Differs From Urinary hCG

Ovidrel contains recombinant choriogonadotropin alfa, produced in Chinese hamster ovary cells. Unlike older urinary-derived hCG products, the recombinant form delivers a consistent, measurable dose with a defined pharmacokinetic profile. Peak serum hCG is reached roughly 12 hours after subcutaneous injection, and the half-life in women is approximately 29 hours. That predictable half-life is the entire reason the 36-hour retrieval window works.

What Illness Disrupts in This System

Acute illness disrupts Ovidrel timing through several intersecting mechanisms:

• Fever accelerates metabolic clearance and may shift the pharmacokinetic curve
• Vomiting and diarrhea cause dehydration, which independently raises ovarian hyperstimulation syndrome (OHSS) risk
• Systemic infection can trigger an inflammatory response that alters follicular fluid chemistry
• Missed stimulation injections during illness may mean follicles are not at the right size when you recover
• Elevated cortisol from physiological stress may transiently suppress LH receptor sensitivity

None of these effects has been tested in a controlled trial specifically examining illness-related trigger delays. That gap is real, and your clinician is extrapolating from mechanistic physiology rather than direct illness-restart data. That honesty matters when you are making this decision.

The Specific Decision Points Your Team Evaluates Before Restarting

Before your reproductive endocrinologist or fertility nurse practitioner clears you to proceed with Ovidrel after an illness, they are working through a structured set of questions. Understanding this framework helps you advocate for yourself in the conversation.

1. Is the Illness Truly Resolved?

The standard threshold used by most reproductive endocrinology practices is resolution of fever (below 38°C / 100.4°F) for at least 24 to 48 hours AND no ongoing systemic symptoms such as rigors, significant nausea, or hemodynamic instability. A respiratory illness that has moved to a mild cough stage is generally acceptable. An active urinary tract infection with dysuria and low-grade fever is not, because ascending genital tract infection in the context of follicle aspiration carries real procedural risk.

2. Where Are Your Follicles Now?

Your clinic will perform a transvaginal ultrasound to assess follicle size before authorizing the trigger. The target for Ovidrel triggering in most IVF protocols is at least one to three lead follicles measuring 17 to 20 mm in mean diameter, with supporting estradiol levels typically in the range of 150 to 250 pg/mL per mature follicle. If illness caused you to miss gonadotropin injections, follicle growth will have stalled. Your team may extend stimulation by two to three additional days before rescanning, or they may recommend cycle cancellation.

3. Has Your Estradiol Trajectory Changed?

A rising estradiol confirms ongoing follicular development. A plateau or drop during your illness days signals that the follicles were not receiving adequate stimulation or that the systemic stress response suppressed granulosa cell function. Your clinic needs at minimum one post-illness estradiol value before proceeding.

4. Is Your OHSS Risk Higher Now?

Dehydration is an independent risk factor for OHSS because reduced intravascular volume makes third-spacing of fluid more likely after the hCG-induced vascular permeability shift. OHSS affects approximately 1 to 2% of IVF cycles in severe form, with mild-to-moderate forms occurring in up to 33% of stimulated cycles. If you were vomiting or had diarrhea for 24 or more hours, your clinic may adjust the trigger strategy, such as substituting a GnRH agonist trigger (leuprolide acetate) if you are in an antagonist protocol and have a fresh embryo transfer planned.

Life-Stage Context: Who Gets Ovidrel and How Illness Hits Differently

Reproductive Years: IVF and IUI Cycles

The majority of Ovidrel users are women aged 25 to 42 in active fertility treatment. In this group, the pressure to avoid cycle cancellation is high, both emotionally and financially. A single IVF cycle costs approximately $12,000 to $15,000 out of pocket on average in the United States, and a cancelled cycle before retrieval represents a significant sunk cost even if medications are partially preserved.

Acute illness in this group needs rapid triage. A 24-hour gastroenteritis with full recovery may allow the cycle to continue with minimal modification. An influenza-like illness with five days of fever and myalgias will almost certainly require cancellation and cycle restart in the following month.

Trying to Conceive With IUI

For women using Ovidrel to trigger ovulation during an intrauterine insemination cycle, the stakes of the exact timing window are somewhat less rigid than IVF, because there is no surgical retrieval to schedule. The trigger still needs to precede insemination by approximately 24 to 40 hours, and illness-related delays may shift the insemination date. A short, mild illness may allow a one-to-two-day delay if follicle monitoring confirms the lead follicle has not yet reached its ceiling and serum LH has not surged spontaneously.

PCOS: A Special Consideration

Women with polycystic ovary syndrome are at substantially higher baseline OHSS risk because of their characteristically high antral follicle counts and elevated AMH. PCOS is present in 70 to 80% of high-responder OHSS cases. If you have PCOS and you are recovering from any dehydrating illness, your team may be especially reluctant to proceed with a standard 250 mcg r-hCG trigger and may prefer either a dose reduction to 125 mcg or a switch to a GnRH agonist trigger, particularly if fresh embryo transfer is planned and a freeze-all strategy is acceptable to you.

Perimenopause and Poor Ovarian Reserve

Women in their early-to-mid forties using Ovidrel with donor eggs or with their own diminished ovarian reserve may have a different risk calculus. Their OHSS risk is lower, but their follicular response is more fragile. A few missed stimulation days due to illness may result in premature luteinization or spontaneous LH surge before the trigger can be given. Your team will check LH on the first post-illness monitoring visit specifically to rule this out.

Pregnancy, Lactation, and Contraception: What You Must Know

Pregnancy

Ovidrel is given to help you become pregnant, not during an established pregnancy. Exogenous hCG is not teratogenic in the doses used for ovulation triggering, but no safety data support using it after implantation, and it serves no therapeutic role post-conception. Because hCG is the same hormone measured in home pregnancy tests, using Ovidrel can cause a false-positive pregnancy test for up to 14 days after injection; confirm pregnancy only with a blood beta-hCG drawn at least 14 days after your trigger.

If you become pregnant in a stimulated cycle, your clinic will monitor progesterone and beta-hCG and may prescribe luteal support (progesterone vaginal suppositories or intramuscular progesterone). Ovidrel itself is not continued into the luteal phase in most contemporary protocols.

Lactation

Ovidrel is not indicated during lactation. Women who are breastfeeding are not candidates for ovarian stimulation cycles in the standard clinical scenario. If a postpartum woman is using ovulation induction for a new pregnancy attempt after weaning, the same clinical framework applies as during the reproductive years. No lactation transfer data for r-hCG are available in the published literature, because the clinical scenario is so uncommon.

Contraception

No contraception requirement applies in the typical use case, because the entire purpose of Ovidrel is to achieve conception. However, if a cycle is cancelled after trigger administration, your team will counsel you on the risk of spontaneous conception during that cycle, since some unintended follicle rupture and ovulation can still occur after r-hCG even without a retrieval. Barrier contraception for that cycle is advisable if you wish to avoid pregnancy in a cancelled cycle.

Managing the 36-Hour Window Around an Illness: Practical Scenarios

Scenario A: Mild 24-Hour Gastroenteritis, Fully Recovered

You vomited twice, could not eat for one day, are now afebrile, and keeping fluids down. Your cycle was on day 9 of stimulation with follicles at 15 to 16 mm. Resolution: your team will rescan in 24 to 48 hours. If follicles have grown to 17 to 20 mm and estradiol is rising, triggering proceeds with standard 250 mcg Ovidrel. Your team may increase oral hydration instructions because of the preceding dehydration.

Scenario B: Influenza With Five Days of Fever

You had 38.5°C fever for five days and missed three gonadotropin injections. Your follicles were at 13 mm when illness started. Resolution: cycle cancellation is the most likely recommendation. Follicles will not have grown appropriately without gonadotropin stimulation, estradiol will have plateaued, and the spontaneous LH surge risk has risen. Your clinic will likely prescribe oral contraceptives to downregulate and schedule a fresh cycle in four to six weeks.

Scenario C: Upper Respiratory Infection, Afebrile, Congested

You have a head cold. No fever. You have been sneezing and congested for three days but continuing your stimulation injections without interruption. Follicles are on track at 18 mm. Resolution: trigger proceeds. A localized upper respiratory illness without systemic features does not alter the safety or pharmacokinetics of Ovidrel in a clinically meaningful way.

Scenario D: Urinary Tract Infection Diagnosed on Retrieval Eve

You have a UTI confirmed by urinalysis, with dysuria and 37.9°C fever, and trigger night is tomorrow. Resolution: this requires same-day antibiotic initiation and reassessment within 12 hours. Most reproductive endocrinologists will delay trigger by 24 to 48 hours if fever has not resolved, to reduce the risk of pelvic infection at the time of transvaginal oocyte retrieval. A single UTI treated appropriately does not require cycle cancellation in most cases.

Communicating With Your Fertility Team: What to Report Immediately

Call your clinic the same day if any of the following occur during an active stimulation cycle:

• Fever at or above 38°C / 100.4°F
• Vomiting or diarrhea lasting more than 12 hours
• Inability to keep any oral fluids down for more than 6 hours
• Abdominal pain or bloating beyond your baseline stimulation discomfort
• Any confirmed or suspected infection requiring antibiotics

Do not wait until your next scheduled monitoring appointment. The fertility cycle moves on a daily calendar, and a 24-hour delay in reporting can mean the difference between a modified plan and a full cancellation.

ASRM recommends individualized cycle management decisions based on clinical presentation, and that individualization depends entirely on the information you give your team in real time.

What the Evidence Does and Does Not Tell Us

There are no prospective randomized trials specifically examining Ovidrel restart protocols after acute illness during ART cycles. The clinical guidance in this area is built from mechanistic pharmacology, OHSS physiology, and reproductive endocrinology expert consensus rather than direct illness-restart data.

What we do know from controlled data:

• The 36-hour trigger-to-retrieval interval is well-validated in multiple large ART cohort studies and is the biological foundation for all timing decisions
• OHSS risk factors are well-characterized and include dehydration, high estradiol, high follicle count, PCOS, and low body weight
• GnRH agonist triggering in antagonist protocols substantially reduces OHSS risk and is an established alternative when hCG trigger carries elevated risk

What we do not know from direct evidence:

• Whether fever at a specific threshold alters r-hCG absorption or half-life in women
• Whether a defined number of missed gonadotropin days during illness predicts poor cycle outcomes
• Whether illness-related cortisol elevation affects oocyte maturation after the Ovidrel trigger

Your clinician is making a judgment call in the absence of this specific evidence. Knowing that helps you have a more honest conversation about the decision.

Who Should Proceed With Ovidrel After Illness and Who Should Wait

Likely Safe to Proceed

• Illness fully resolved for 48 or more hours
• Afebrile, tolerating oral fluids and food normally
• Stimulation injections continued without interruption or with only one day missed
• Follicles at target size on post-illness scan
• Estradiol rising and appropriate for follicle cohort
• No active infection or antibiotic course still in progress

Requires Caution or Protocol Modification

• Resolved illness but preceding dehydration of 24 or more hours (consider hydration bolus, lower trigger dose or GnRH agonist trigger in eligible patients, freeze-all strategy)
• PCOS diagnosis plus any dehydrating illness, even if mild
• UTI treated but <48 hours into antibiotics at time of planned trigger
• Women with a prior OHSS episode in any previous cycle

Likely Requires Cancellation

• Fever persisting at trigger time
• Active systemic infection not yet adequately treated
• Three or more missed stimulation injections with follicles below 14 mm
• Spontaneous LH surge confirmed before trigger can be given
• Clinical instability from illness (dehydration requiring IV fluids, hospitalization)

Injection Technique and Storage After a Sick Day

If your Ovidrel prefilled syringe sat at room temperature because you were too ill to refrigerate it properly, check the product labeling. Ovidrel should be stored at 2 to 8°C (36 to 46°F) when not in use. The product may be stored at room temperature up to 25°C (77°F) for up to 30 days, but should not be used if it has been exposed to temperatures above 25°C or if the solution appears discolored or contains particles. On a sick day when you may have been running a fever and the house was warm, confirm storage conditions before using the syringe. If in doubt, call your pharmacy for a replacement.

FAQs